Clinical Trials Browser

Interventional × Telmisartan × 1 year × Clear all

NCT07370506 2026-01-29

Telmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT06815497 2026-01-28

Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer

Phase 2 Recruiting

Ovarian Neoplasms

NCT06168487 2025-08-21

Telmisartan in Prostate Cancer

Phase 1 Recruiting

Prostatic Neoplasms